KraneShares MSCI All China Health Care Index 

$16.34
0
-$0.51-3.03% Monday 04:46

Statistics

Day High
16.71
Day Low
16.33
52W High
-
52W Low
-
Volume
1,186
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
4.37%
Dividend
0.71

Upcoming

Dividends

4.37%Dividend Yield
Dec 25
$0.71
Dec 24
$0.18
Dec 23
$0.11
Dec 22
$0.01
Dec 21
$4.05
10Y Growth
N/A
5Y Growth
-29.33%
3Y Growth
85.02%
1Y Growth
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow KURE.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
State Street SPDR S&P China
GXC
Mkt Cap0
SPDR S&P China ETF tracks a broad-based, cap-weighted index of Chinese stocks, including health care, offering a diversified exposure to China's economy but competing with KURE in the healthcare segment.
iShares MSCI China
MCHI
Mkt Cap0
iShares MSCI China ETF tracks the MSCI China Index, which includes stocks across all sectors, including health care. It competes with KURE by offering exposure to Chinese healthcare companies as part of its broader portfolio.
KraneShares CSI China Internet
KWEB
Mkt Cap0
KraneShares CSI China Internet ETF focuses on Chinese internet companies, some of which are involved in health technology and services, indirectly competing with KURE in the healthcare technology space.
Xtrackers Harvest CSI 300 China A-Shares
ASHR
Mkt Cap0
Deutsche X-trackers Harvest CSI 300 China A-Shares ETF tracks the CSI 300 Index, which includes healthcare stocks among its largest components, competing with KURE for investors seeking exposure to Chinese healthcare.
iShares China Large-Cap
FXI
Mkt Cap0
iShares China Large-Cap ETF tracks the FTSE China 50 Index, including large-cap Chinese stocks across various sectors, including health care, thus competing with KURE for investment in the Chinese healthcare sector.
Invesco China Technology
CQQQ
Mkt Cap0
Invesco China Technology ETF focuses on technology in China, including health tech companies, making it a competitor to KURE by offering exposure to the tech side of healthcare.
WisdomTree China ex-State-Owned Enterprises Fund
CXSE
Mkt Cap0
WisdomTree China ex-State-Owned Enterprises Fund excludes SOEs and includes private healthcare companies, competing with KURE by targeting a different segment of the Chinese healthcare market.
Invesco Golden Dragon China
PGJ
Mkt Cap0
Invesco Golden Dragon China ETF tracks the NASDAQ Golden Dragon China Index, which includes U.S.-listed companies that derive a majority of their revenue from China, including healthcare firms, competing with KURE.

About

The fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in instruments in its underlying index or in instruments that have economic characteristics similar to those in the underlying index. The underlying index is a free float adjusted market capitalization weighted index, subject to the 10/40 Constraint, which is designed to measure the equity market performance of Chinese companies in the healthcare sector. The fund is non-diversified.
Show more...
CEO
ISIN
US5007678353

Listings

0 Comments

Share your thoughts

FAQ

What is KraneShares MSCI All China Health Care Index stock price today?
The current price of KURE.BOATS is $16.34 USD — it has decreased by -3.03% in the past 24 hours. Watch KraneShares MSCI All China Health Care Index stock price performance more closely on the chart.
What is KraneShares MSCI All China Health Care Index stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange KraneShares MSCI All China Health Care Index stocks are traded under the ticker KURE.BOATS.
Does KraneShares MSCI All China Health Care Index pay dividends?
Yes, KURE.BOATS dividends are paid annual. The last dividend per share was 0.71 USD. As of today, Dividend Yield (FWD)% is 4.37%.
When did KraneShares MSCI All China Health Care Index complete a stock split?
KraneShares MSCI All China Health Care Index has not had any recent stock splits.